KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Retained Earnings (2016 - 2025)

Fulgent Genetics' Retained Earnings history spans 10 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 2141.3% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $7.5 million, up 2141.3%, while the annual FY2025 figure was $7.5 million, 2141.3% up from the prior year.
  • Retained Earnings for Q4 2025 was $7.5 million at Fulgent Genetics, up from $6.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $823.1 million in Q2 2022 and bottomed at -$25.6 million in Q3 2022.
  • The 5-year median for Retained Earnings is -$240500.0 (2021), against an average of $165.2 million.
  • The largest YoY upside for Retained Earnings was 375829.63% in 2022 against a maximum downside of 2654.02% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$759000.0 in 2021, then tumbled by 2654.02% to -$20.9 million in 2022, then soared by 3129.11% to $633.2 million in 2023, then crashed by 100.06% to -$368000.0 in 2024, then soared by 2141.3% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Retained Earnings are $7.5 million (Q4 2025), $6.8 million (Q3 2025), and $560.0 million (Q2 2025).